Priority Date: 10.09.12 (US 201261699071P)

INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA

  • Application ID: EP13836112
  • Status: GRANT OF PATENT INTENDED

Applicant

Company dna yeda research and development co ltd
Technology Transfer Office

Attorney

no operation time available
1262.32
4 offices
active in Legal Services

Specialization

This EP application has the IPC combination A01, A61, and G01. We found, that Coller IP Management Ltd, Kailuweit & Uhlemann, Vereenigde Octrooibureaux NV (V.O.), ip21 Ltd, Riederer Hasler & Partner Patentanwälte AG and 25 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.09.2012 - Priority Date (US 201261699071P)
  • 13.03.2014 - Publication A1 (WO2014037952)
  • 15.07.2015 - Publication A1 (EP2892353)

IPC Classification